Hepcidin: The Master Regulator of Iron Metabolism
Hepcidin is a 25-amino acid peptide hormone produced primarily in the liver that functions as the principal iron-regulatory hormone in the body, controlling iron absorption, recycling, and tissue distribution by binding to ferroportin (the sole cellular iron exporter) on enterocytes and macrophages, causing its internalization and degradation. 1
Structure and Production
- Hepcidin is a cysteine-rich peptide containing 25 amino acids with four disulfide bridges 2, 3
- Synthesized in the liver as a precursor protein (prohepcidin) that is processed to produce the biologically active mature peptide 3
- Secreted into circulation where it acts systemically 1
Physiological Function
Hepcidin regulates iron homeostasis through several key mechanisms:
Intestinal iron absorption control: Binds to ferroportin on duodenal enterocytes, causing internalization and degradation of this iron exporter, thereby limiting dietary iron absorption 1, 4
Macrophage iron recycling regulation: Controls the release of iron from macrophages that recycle senescent erythrocytes 4, 5
Hepatic iron storage management: Regulates iron mobilization from liver stores 5
Placental iron transport: Decreases iron transport across the placenta 2
Regulation of Hepcidin Production
Hepcidin synthesis is regulated by multiple factors:
Iron status:
Erythropoietic activity:
- Suppressed during increased erythropoiesis, partly through erythroferrone (a hormone produced by erythropoietin-stimulated erythroblasts) 4
- This suppression increases iron availability for red blood cell production
Inflammation and infection:
Hypoxia: Decreased during hypoxic conditions 5
Role in Disease
Hepcidin dysregulation is implicated in various iron disorders:
Hepcidin Deficiency Conditions
- Hereditary hemochromatosis: Most forms result from hepcidin deficiency or resistance to hepcidin action 1, 4, 5
- Iron-loading anemias: Including β-thalassemia, where ineffective erythropoiesis leads to hepcidin suppression and iron overload 4
Hepcidin Excess Conditions
- Iron-refractory iron deficiency anemia (IRIDA): Caused by mutations in matriptase-2/TMPRSS6 (a hepcidin suppressor) 2
- Anemia of inflammation: Elevated hepcidin restricts iron availability for erythropoiesis 4, 6
- Anemia of chronic kidney disease: Increased hepcidin contributes to functional iron deficiency 4
Clinical Significance
- Diagnostic potential: Hepcidin measurement may help diagnose and differentiate various iron disorders 6
- Therapeutic target: Central role in iron disorders makes hepcidin an important target for developing new treatments 4, 6
- Antimicrobial properties: Initially identified as an antimicrobial peptide, hepcidin has defensive roles against infections by limiting iron availability to pathogens 2
Important Considerations
- Hepcidin's biological activity depends on proper folding and disulfide bridge formation 3
- Storage and handling conditions can lead to formation of biologically inactive aggregated forms 3
- The discovery of hepcidin has revolutionized our understanding of systemic iron disorders and provides new opportunities for improved diagnosis and treatment 5